Debate: ‘Safety, adequacy, cost’ still favor percutaneous vs. endoscopic ultrasound biopsy

SAN DIEGO — Although percutaneous liver biopsy is still the “gold standard,” advances in techniques and increased use of endoscopic ultrasound-guided biopsy may soon change that dynamic, according to a debate at Digestive Disease Week 2022.“There are several advantages to [endoscopic ultrasound (EUS)-guided liver biopsy], not the least of which is patient comfort,” David L. Diehl, MD, FASGE, of Geisinger Medical Center in Danville, Pennsylvania, told attendees. “It provides outstanding sample yields with the current techniques, and it’s possible to doRead More